Author

S. D. Scherer

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Bioengineering· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:human· 3 Research Focus:drug response / drug discovery· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:clustering· 1 Research Focus:differential expression· 1 Assay:imaging· 1

Frequent Co-Authors

A. L. Welm· 2 shared B. E. Welm· 2 shared E. Cortes-Sanchez· 2 shared T. A. Zangle· 2 shared A. Butterfield· 1 shared A. C. Beck· 1 shared A. J. Butterfield· 1 shared B. T. Spike· 1 shared

Activity by Year

2021-2021 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

A. L. Welm

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Multiparametric quantitative phase imaging for real-time, single cell, drug screening in breast cancer

E. R. Polanco, T. E. Moustafa, A. Butterfield, S. D. Scherer, E. Cortes-Sanchez, T. Bodily, B. T. Spike, B. E. Welm, P. S. Bernard, T. A. Zangle

This study uses multiparametric quantitative phase imaging to assess drug response in breast cancer cells, revealing single-cell heterogeneity and resistance dynamics.

bioRxiv · Nov 26, 2021Bioengineering

Laterally transferred macrophage mitochondria acts as a signaling source promoting cancer cell proliferation

C. U. Kidwell, J. R. Casalini, S. Pradeep, S. D. Scherer, D. Greiner, J. S. Johnson, G. S. Olson, J. Rutter, A. L. Welm, T. A. Zangle, M. Roh-Johnson

The paper shows that dysfunctional macrophage mitochondria transferred to cancer cells promote proliferation via ROS-induced ERK signaling.

bioRxiv · Aug 10, 2021Cancer Biology

A breast cancer patient-derived xenograft and organoid platform for drug discovery and precision oncology

K. P. Guillen, M. Fujita, A. J. Butterfield, S. D. Scherer, M. H. Bailey, Z. Chu, Y. S. DeRose, L. Zhao, E. Cortes-Sanchez, C.-H. Yang, J. Toner, G. Wang, Y. Qiao, X. Huang, J. A. Greenland, , A. L. Welm

The paper develops patient-derived xenografts and organoids for breast cancer to enable drug screening and precision oncology, showing efficacy of an FDA-approved drug in a clinical case.

bioRxiv · Feb 28, 2021 · PreprintCancer Biology